| Literature DB >> 28693149 |
Hongzhen Du1, Bingbing Liu1, Ying Xie1, Jinli Liu1, Yujia Wei1, Huanyu Hu1, Bin Luo1, Zengning Li1.
Abstract
Nutrition screening to identify patients at risk of malnutrition is vital for cancer patients because of the high prevalence of malnutrition in this population. The aim of the present study was to compare different methods of nutrition assessment in patients with tumors. From June 2013 to June 2014, we conducted an observational multicenter study to compare the assessment of nutritional status in patients with tumors by anthropometry, biochemical indicators, nutritional risk screening (NRS-2002) and patient-generated subjective global assessment (PG-SGA). Mann-Whitney test and Kruskal-Wallis H non-parametric test were used for intergroup comparisons. Spearmans rank correlation coefficients were calculated to evaluate the association between different methods of nutritional assessment. The κ statistic was used to evaluate the agreement between two assessment methods. A total of 927 oncology inpatients underwent full nutritional assessment and nutrition screening. The PG-SGA tool determined that 13.7% of patients were well-nourished (PG-SGA from 0-1) and the rest (86.3%) were malnourished. Among the malnourished patients, 57.8% were moderately malnourished (PG-SGA from 2-8) and 28.5% were severely malnourished (PG-SGA ≥9). According to NRS-2002, 30.7% of patients were at nutritional risk (NRS-2002 ≥3). There was a significant positive correlation between PG-SGA scores and NRS-2002 scores in both men and women. Compared to albumin, the PG-SGA had a sensitivity of 93.78% and specificity of 21.80%. In comparison, NRS-2002 had a low sensitivity of 43.13% and relatively higher specificity of 82.16%. In conclusion, the relationship between PG-SGA, NRS-2002 and nutritional status is statistically significant. Compared with NRS-2002, PG-SGA is a suitable screening tool for detecting the risk of malnutrition in patients with cancer.Entities:
Keywords: malignant tumor; nutritional risk screening; patient-generated subjective global assessment
Year: 2017 PMID: 28693149 PMCID: PMC5494893 DOI: 10.3892/ol.2017.6154
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967
Clinical characteristics of the patients.
| Clinical characteristics | Total (n=927) | Men (n=510) | Women (n=417) |
|---|---|---|---|
| Age, median (IQR) | 61 (52–78) | 62 (55–70) | 59 (48–66) |
| Nutritional parameters, median (IQR) | |||
| Weight, kg | 61 (52–68) | 65 (59–70) | 58 (52–64.63)[ |
| BMI, kg/m2 | 22.3 (20.3–24.5) | 22.10 (20.3–23.93) | 22.7 (20.6–25.2)[ |
| TSF, mm | 12.0 (8.1–15) | 10.05 (8–13.63) | 13.0 (9–16)[ |
| MAC, cm | 27.0 (23.5–30.0) | 27.0 (24–30.0) | 26.25 (23–30.0) |
| MAMC, cm | 22.72 (20.29–25.45) | 23.13 (21.17–25.92) | 22.08 (18.73–24.56)[ |
| Non-dominant hand grip, kg | 16.7 (10–24) | 20 (12–27.93) | 14.05 (10–20)[ |
| Total protein, g/l | 65 (59.2–71) | 64.75 (59.18–70.93) | 66.80 (60.15–71.75) |
| Albumin, g/l | 38.2 (34.1–42) | 38 (34.00–42.00) | 39 (35.45–41.80) |
| Hemoglobin, mg/l | 117.0 (102–129) | 118.0 (102–132) | 115.0 (101–127)[ |
| Tumor location, n (%) | |||
| Esophageal cancer | 44 (4.7) | 31 (6.1) | 13 (3.1) |
| Malignant neoplasm of cerebrum brain | 8 (9) | 5 (1.0) | 3 (7.0) |
| Lung cancer | 179 (19.3) | 112 (22.0) | 67 (16.1) |
| Breast cancer | 63 (6.8) | 2 (0.4) | 61 (14.6) |
| Colon/rectal cancer | 169 (18.2) | 90 (17.6) | 79 (18.9) |
| Bladder cancer | 2 (0.2) | 1 (0.2) | 1 (0.2) |
| Gastric cancer | 143 (15.4) | 107 (21.0) | 36 (8.6) |
| Endometrial cancer | 8 (0.9) | 0 (0) | 8 (1.9) |
| Ovarian cancer | 20 (2.2) | 0 (0) | 20 (4.8) |
| Cervical cancer | 14 (1.5) | 0 (0) | 14 (3.4) |
| Malignant lymphoma | 25 (2.7) | 11 (2.2) | 14 (3.4) |
| Liver cancer | 107 (11.5) | 64 (12.5) | 43 (10.3) |
| Nasopharyngeal cancer | 11 (1.2) | 10 (2.0) | 1 (0.2) |
| Pancreatic cancer | 17 (1.8) | 7 (1.4) | 10 (2.4) |
| Prostate cancer | 5 (0.5) | 5 (1.0) | 0 (0) |
| Leukemia | 112 (12.1) | 65 (12.7) | 47 (11.3) |
P<0.001
P<0.05 by Mann-Whitney test. IQR, interquartile range; BMI, body mass index; TSF, triceps skinfold thickness; MAC, mid-arm circumference; MAMC, mid-arm muscle circumference.
Figure 1.Different types of cancer patients with categorisation of malnutrition by PG-SGA. PG-SGA, patient-generated subjective global assessment.
Comparison of nutritional indicators (median, IQR) according to PG-SGA.
| PG-SGA | |||
|---|---|---|---|
| Nutritional parameters | A[ | B[ | C[ |
| Weight, kg | 65 (60–72) | 63 (56–70) | 58 (50–62)[ |
| BMI, kg/m2 | 24 (22–26) | 22.6 (20.8–24.8) | 21.1 (19.03–22.98)[ |
| MAC, cm | 28.5 (26.5–31.25) | 27.5 (24.3–30) | 24 (20.4–27.00)[ |
| TSF, mm | 14.1 (10–20.5) | 12.5 (8.4–15) | 9.05 (8–12.33)[ |
| Non-dominant hand grip, kg | 21.1 (16.4–29.75) | 17 (10–24) | 14 (9–20)[ |
| MAMC, cm | 23.87 (22.14–25.76) | 23.2 (20.72–25.89) | 21.3 (17.75–23.23)[ |
| Total protein, g/l | 68.6 (65.0–73.5) | 66.2 (60.0–72.1) | 60.2 (57.67–66.2)[ |
| Albumin, g/l | 41 (38.2–43.25) | 38.8 (34.7–42.7) | 35.8 (32.43–40.0)[ |
| Hemoglobin, mg/l | 124.0 (114.0–134.5) | 116.0 (100.0–128.0) | 115.0 (101.0–134.5)[ |
A, PG-SGA rating in well-nourished patients.
B, PG-SGA rating in moderately undernourished patients.
C, PG-SGA rating in severely undernourished patients.
P<0.001, P<0.05 by Mann-Whitney test. IQR, interquartile range; PG-SGA, patient-generated subjective global assessment; BMI, body mass index; MAC, mid-arm circumference; TSF, triceps skinfold thickness; MAMC, mid-arm muscle circumference.
Correlation coefficients and P-values for patient data and nutritional assessment techniques according to sex.
| PG-SGA | NRS-2002 | |||||||
|---|---|---|---|---|---|---|---|---|
| Men | Women | Men | Women | |||||
| Nutritional parameters | Correlation | P-value | Correlation | P-value | Correlation | P-value | Correlation | P-value |
| Weight, kg | −0.296 | <0.001 | −0.350 | <0.001 | −0.341 | <0.001 | −0.418 | <0.001 |
| BMI, kg/m2 | −0.305 | <0.001 | −0.355 | <0.001 | −0.336 | <0.001 | −0.417 | <0.001 |
| TSF, mm | −0.224 | <0.001 | −0.343 | <0.001 | −0.207 | <0.001 | −0.332 | <0.001 |
| MAC, cm | −0.294 | <0.001 | −0.417 | <0.001 | −0.266 | <0.001 | −0.395 | <0.001 |
| MAMC, cm | −0.237 | <0.001 | −0.321 | <0.001 | −0.222 | <0.001 | −0.295 | <0.001 |
| Non-dominant hand grip, kg | −0.333 | <0.001 | −0.219 | <0.001 | −0.324 | <0.001 | −0.239 | <0.001 |
| Total protein, g/l | −0.323 | <0.001 | −0.333 | <0.001 | −0.319 | <0.001 | −0.313 | <0.001 |
| Albumin, g/l | −0.271 | <0.001 | −0.376 | <0.001 | −0.297 | <0.001 | −0.264 | <0.001 |
| Hemoglobin, mg/l | −0.214 | <0.001 | −0.165 | 0.001 | −0.266 | <0.001 | −0.255 | 0.001 |
| NRS-2002 score | 0.543 | <0.001 | 0.575 | <0.001 | ||||
All P-values were determined with the use of Spearmans correlation coefficient. PG-SGA, patient-generated subjective global assessment; NRS-2002, nutritional risk screening; BMI, body mass index; TSF, triceps skinfold thickness; MAC, mid-arm circumference; MAMC, mid-arm muscle circumference.
Statistical comparison of albumin and screening tool values at hospital admission: PG-SGA and NRS-2002 vs. albumin.
| PG-SGA | NRS-2002 | |||||
|---|---|---|---|---|---|---|
| Items | At risk (B+C) | No risk (A) | Total | At risk (NRS-2002 ≥3) | No risk (NRS-2002 <3) | Total |
| At risk (albumin <35g/l) | 452 | 30 | 482 | 204 | 269 | 473 |
| No risk (albumin ≥35g/l) | 348 | 97 | 445 | 81 | 373 | 454 |
| Total | 800 | 127 | 927 | 285 | 642 | 927 |
| Sensitivity | 93.78% (454/482) | 43.13% (204/473) | ||||
| Specificity | 21.80% (97/445) | 82.16% (373/454) | ||||
| κ=0.160, P=0.0006 | κ=0.251, P=0.0007 | |||||
PG-SGA, patient-generated subjective global assessment; NRS-2002, nutritional risk screening.